These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 16709843
1. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene. Jacobsen EA, Ananieva O, Brown ML, Chang Y. J Immunol; 2006 Jun 01; 176(11):6831-8. PubMed ID: 16709843 [Abstract] [Full Text] [Related]
2. NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression. Nakamura Y, Grumont RJ, Gerondakis S. Mol Cell Biol; 2002 Aug 01; 22(15):5563-74. PubMed ID: 12101248 [Abstract] [Full Text] [Related]
3. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling. Banerjee A, Rothman P. J Immunol; 1998 Nov 01; 161(9):4611-7. PubMed ID: 9794389 [Abstract] [Full Text] [Related]
9. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain. Mainville CA, Parmar K, Unnikrishnan I, Gong L, Raffel GD, Rosenberg N. J Virol; 2001 Feb 15; 75(4):1816-23. PubMed ID: 11160680 [Abstract] [Full Text] [Related]
10. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Chen YY, Rosenberg N. Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):6683-7. PubMed ID: 1379715 [Abstract] [Full Text] [Related]
11. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes. Clark SS, Liang Y, Reedstrom CK, Wu SQ. Blood; 1994 Dec 15; 84(12):4301-9. PubMed ID: 7994046 [Abstract] [Full Text] [Related]
12. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Muljo SA, Schlissel MS. Nat Immunol; 2003 Jan 15; 4(1):31-7. PubMed ID: 12469118 [Abstract] [Full Text] [Related]
14. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo. Zou X, Cong F, Coutts M, Cattoretti G, Goff SP, Calame K. Mol Cell Biol; 2000 Jan 15; 20(2):628-33. PubMed ID: 10611241 [Abstract] [Full Text] [Related]
16. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus. Noronha EJ, Sterling KH, Calame KL. J Biol Chem; 2003 Dec 19; 278(51):50915-22. PubMed ID: 14559912 [Abstract] [Full Text] [Related]
17. Inhibition of v-Abl transformation by p53 and p19ARF. Cong F, Zou X, Hinrichs K, Calame K, Goff SP. Oncogene; 1999 Dec 16; 18(54):7731-9. PubMed ID: 10618713 [Abstract] [Full Text] [Related]
18. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. Renshaw MW, Kipreos ET, Albrecht MR, Wang JY. EMBO J; 1992 Nov 16; 11(11):3941-51. PubMed ID: 1396587 [Abstract] [Full Text] [Related]
19. Pre-B-cells transformed by ts Abelson virus rearrange kappa and lambda [correction of gamma] genes in early G1. Wang LC, Chen YY, Rosenberg N. Curr Top Microbiol Immunol; 1995 Nov 16; 194():355-61. PubMed ID: 7895509 [No Abstract] [Full Text] [Related]
20. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. Largaespada DA, Kaehler DA, Mishak H, Weissinger E, Potter M, Mushinski JF, Risser R. Oncogene; 1992 Apr 16; 7(4):811-9. PubMed ID: 1565479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]